161 related articles for article (PubMed ID: 26759404)
1. Etanercept-induced myositis: do we have to stop it? A surprising outcome.
Tariq H; Ayesha B; Weidenheim K; Franchin G
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759404
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
Sterry W; Ortonne JP; Kirkham B; Brocq O; Robertson D; Pedersen RD; Estojak J; Molta CT; Freundlich B
BMJ; 2010 Feb; 340():c147. PubMed ID: 20124563
[TBL] [Abstract][Full Text] [Related]
3. The Paradoxical Induction of Crohn’s Disease Following Treatment of Psoriatic Arthritis With Etanercept.
Forouzandeh M; Vazquez T; Nouri K; Forouzandeh B
J Drugs Dermatol; 2019 Aug; 18(8):832-834. PubMed ID: 31424717
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis after etanercept and ustekinumab treatment for psoriatic arthritis: A case report.
Nicocia G; Bonanno C; Lupica A; Toscano A; Rodolico C
Neuromuscul Disord; 2020 Mar; 30(3):246-249. PubMed ID: 32057636
[TBL] [Abstract][Full Text] [Related]
5. Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.
Kamarashev J; Lor P; Forster A; Heinzerling L; Burg G; Nestle FO
Dermatology; 2002; 205(2):213-6. PubMed ID: 12218252
[TBL] [Abstract][Full Text] [Related]
6. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
[TBL] [Abstract][Full Text] [Related]
7. Extracapillary glomerulonephritis during etanercept treatment for juvenile psoriatic arthritis.
Menè P; Franeta AJ; Conti G; Stoppacciaro A; Chimenz R; Fede A; Gallizzi R; Fede C
Clin Exp Rheumatol; 2010; 28(1):91-3. PubMed ID: 20346246
[TBL] [Abstract][Full Text] [Related]
8. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
[TBL] [Abstract][Full Text] [Related]
9. D-penicillamine-induced myositis in rheumatoid arthritis.
Chappel R; Willems J
Clin Rheumatol; 1996 Jan; 15(1):86-7. PubMed ID: 8929785
[TBL] [Abstract][Full Text] [Related]
10. Pyogenic Baker cyst in a patient with psoriatic arthritis during etanercept therapy.
Wu KY; Yang DH; Chen CW
Ann Saudi Med; 2015; 35(3):260-2. PubMed ID: 26409803
[TBL] [Abstract][Full Text] [Related]
11. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with etanercept monotherapy in a hemodialyzed patient with moderate-to-severe plaque-type psoriasis and psoriatic arthritis.
Babino G; Esposito M; Bianchi L; Giunta A
G Ital Dermatol Venereol; 2018 Dec; 153(6):882-884. PubMed ID: 29144096
[No Abstract] [Full Text] [Related]
14. Etanercept in the treatment of psoriatic arthritis.
Puig L; López-Ferrer A; Laiz A
Actas Dermosifiliogr; 2015 May; 106(4):252-9. PubMed ID: 25455504
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of high serum creatine kinase levels in systemic lupus erythematosus.
Richter JG; Becker A; Ostendorf B; Specker C; Stoll G; Neuen-Jacob E; Schneider M
Rheumatol Int; 2003 Nov; 23(6):319-23. PubMed ID: 12739036
[TBL] [Abstract][Full Text] [Related]
16. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
Mease PJ; Goffe BS; Metz J; VanderStoep A; Finck B; Burge DJ
Lancet; 2000 Jul; 356(9227):385-90. PubMed ID: 10972371
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary sarcoidosis associated with etanercept therapy.
Farah RE; Shay MD
Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
[TBL] [Abstract][Full Text] [Related]
18. [Case of eosinophilic myositis in continuum from localized nodular myositis].
Matsuse D; Ikezoe K; Shigeto H; Murai H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2008 Jan; 48(1):36-42. PubMed ID: 18386630
[TBL] [Abstract][Full Text] [Related]
19. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
20. Effect of calcipotriol on etanercept partial responder psoriasis vulgaris and psoriatic arthritis patients.
Campione E; Mazzotta A; Paternò EJ; Diluvio L; Prinz JC; Chimenti S
Acta Derm Venereol; 2009; 89(3):288-91. PubMed ID: 19479128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
